Lepisosteus oculatus isolate Spotted Gar 1 linkage group LG21, LepOcu1, whole genome shotgun sequence.
Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Actinopterygii; Neopterygii; Holostei; Semionotiformes; Lepisosteidae; Lepisosteus.
REFSEQ INFORMATION: The reference sequence is identical to\nCM001424.1.\nAssembly name: LepOcu1\nThe genomic sequence for this RefSeq record is from the\nwhole-genome assembly released by the Broad Institute on\n2012/01/13. The original whole-genome shotgun project has the\naccession AHAT00000000.1.\n\n##Genome-Assembly-Data-START##\nAssembly Provider :: Broad Institute\nAssembly Method :: AllPaths v. R38293\nAssembly Name :: LepOcu1\nGenome Coverage :: 677.5x\nSequencing Technology :: Illumina HiSeq\n##Genome-Assembly-Data-END##\n\n##Genome-Annotation-Data-START##\nAnnotation Provider :: NCBI\nAnnotation Status :: Full annotation\nAnnotation Version :: Lepisosteus oculatus Annotation\n Release 101\nAnnotation Pipeline :: NCBI eukaryotic genome annotation\n pipeline\nAnnotation Software Version :: 6.5\nAnnotation Method :: Best-placed RefSeq; Gnomon\nFeatures Annotated :: Gene; mRNA; CDS; ncRNA\n##Genome-Annotation-Data-END##
USA: Bayou Chevreuil, St. James Parish, Louisiana
Derived by automated computational analysis using gene prediction method: Gnomon.
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
glutamate receptor, ionotropic, N-methyl D-aspartate 1, transcript variant X13
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 3 ESTs, 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
glutamate receptor, ionotropic, N-methyl D-aspartate 1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 3 ESTs, 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
glutamate receptor, ionotropic, N-methyl D-aspartate 1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 3 ESTs, 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
glutamate receptor, ionotropic, N-methyl D-aspartate 1, transcript variant X4
glutamate receptor, ionotropic, N-methyl D-aspartate 1, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 2 ESTs, 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
glutamate receptor, ionotropic, N-methyl D-aspartate 1, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 2 ESTs, 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
glutamate receptor, ionotropic, N-methyl D-aspartate 1, transcript variant X10
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 3 ESTs, 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
glutamate receptor, ionotropic, N-methyl D-aspartate 1, transcript variant X8
glutamate receptor, ionotropic, N-methyl D-aspartate 1, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 3 ESTs, 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
glutamate receptor, ionotropic, N-methyl D-aspartate 1, transcript variant X9
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 3 ESTs, 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
glutamate receptor, ionotropic, N-methyl D-aspartate 1, transcript variant X12
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 2 ESTs, 13 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
glutamate receptor, ionotropic, N-methyl D-aspartate 1, transcript variant X11
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 3 ESTs, 16 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
glutamate receptor, ionotropic, N-methyl D-aspartate 1, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 3 ESTs, 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
glutamate receptor ionotropic, NMDA 1 isoform X12
glutamate receptor ionotropic, NMDA 1 isoform X6
glutamate receptor ionotropic, NMDA 1 isoform X5
glutamate receptor ionotropic, NMDA 1 isoform X11
glutamate receptor ionotropic, NMDA 1 isoform X13
glutamate receptor ionotropic, NMDA 1 isoform X3
glutamate receptor ionotropic, NMDA 1 isoform X10
glutamate receptor ionotropic, NMDA 1 isoform X9
glutamate receptor ionotropic, NMDA 1 isoform X8
glutamate receptor ionotropic, NMDA 1 isoform X7
glutamate receptor ionotropic, NMDA 1 isoform X4
glutamate receptor ionotropic, NMDA 1 isoform X2
glutamate receptor ionotropic, NMDA 1 isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
solute carrier family 31 (copper transporter), member 1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 16 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 22 samples with support for all annotated introns
solute carrier family 31 (copper transporter), member 1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 16 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
high affinity copper uptake protein 1 isoform X1
solute carrier family 31 (copper transporter), member 1, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 16 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 21 samples with support for all annotated introns
high affinity copper uptake protein 1 isoform X2
cell division cycle 26, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 22 samples with support for all annotated introns
cell division cycle 26, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 21 samples with support for all annotated introns
anaphase-promoting complex subunit CDC26
pre-mRNA processing factor 4, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 22 samples with support for all annotated introns
pre-mRNA processing factor 4, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 18 samples with support for all annotated introns
pre-mRNA processing factor 4, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
U4/U6 small nuclear ribonucleoprotein Prp4
ring finger protein 224, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
ring finger protein 224, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
ring finger protein 224, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
ring finger protein 224, transcript variant X3
ring finger protein 208, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
ring finger protein 208, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
ring finger protein 208, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
ring finger protein 208, transcript variant X2
ring finger protein 208, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
ring finger protein 208, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
ring finger protein 208, transcript variant X4
E3 ubiquitin-protein ligase TRIM56-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
E3 ubiquitin-protein ligase TRIM56-like, transcript variant X1
E3 ubiquitin-protein ligase TRIM56-like, transcript variant X2
E3 ubiquitin-protein ligase TRIM56-like, transcript variant X4
aminolevulinate dehydratase, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 22 samples with support for all annotated introns
aminolevulinate dehydratase, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
delta-aminolevulinic acid dehydratase isoform X1
delta-aminolevulinic acid dehydratase isoform X2
transmembrane protein 203, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 22 samples with support for all annotated introns
transmembrane protein 203, transcript variant X1
transmembrane protein 203, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 21 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 21 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 22 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 20 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 18 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 22 samples with support for all annotated introns
chromosome LG21 open reading frame, human C9orf91, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
chromosome LG21 open reading frame, human C9orf91, transcript variant X7
chromosome LG21 open reading frame, human C9orf91, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
chromosome LG21 open reading frame, human C9orf91, transcript variant X8
chromosome LG21 open reading frame, human C9orf91, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
chromosome LG21 open reading frame, human C9orf91, transcript variant X4
chromosome LG21 open reading frame, human C9orf91, transcript variant X3
chromosome LG21 open reading frame, human C9orf91, transcript variant X5
transmembrane protein C9orf91 homolog isoform X1
transmembrane protein C9orf91 homolog isoform X4
transmembrane protein C9orf91 homolog isoform X2
transmembrane protein C9orf91 homolog isoform X5
transmembrane protein C9orf91 homolog isoform X3
F-box and WD repeat domain containing 5, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 22 samples with support for all annotated introns
F-box and WD repeat domain containing 5, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
TNF receptor associated factor 2, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
TNF receptor associated factor 2, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
TNF receptor associated factor 2, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 17 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
ubiquinone biosynthesis protein COQ4 homolog, mitochondrial isoform X1
ubiquinone biosynthesis protein COQ4 homolog, mitochondrial isoform X3
ubiquinone biosynthesis protein COQ4 homolog, mitochondrial isoform X4
ubiquinone biosynthesis protein COQ4 homolog, mitochondrial isoform X2
TruB pseudouridine (psi) synthase family member 2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 22 samples with support for all annotated introns
ectonucleoside triphosphate diphosphohydrolase 2, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
ectonucleoside triphosphate diphosphohydrolase 2, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
ectonucleoside triphosphate diphosphohydrolase 2, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
ectonucleoside triphosphate diphosphohydrolase 2, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
ectonucleoside triphosphate diphosphohydrolase 2 isoform X1
ectonucleoside triphosphate diphosphohydrolase 2 isoform X2
B-box and SPRY domain containing, transcript variant X2
B-box and SPRY domain containing, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
B box and SPRY domain-containing protein isoform X2
B box and SPRY domain-containing protein isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 22 samples with support for all annotated introns
zinc finger MYND domain-containing protein 19
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 97% coverage of the annotated genomic feature by RNAseq alignments
uncharacterized LOC107079811, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
uncharacterized LOC107079811, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
transmembrane protein 141, transcript variant X3
transmembrane protein 141, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
transmembrane protein 141, transcript variant X1
coiled-coil domain containing 183, transcript variant X1
coiled-coil domain containing 183, transcript variant X2
coiled-coil domain-containing protein 183 isoform X1
coiled-coil domain-containing protein 183 isoform X2
suppressor APC domain-containing protein 2-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 85% coverage of the annotated genomic feature by RNAseq alignments
ectonucleoside triphosphate diphosphohydrolase 2-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
ectonucleoside triphosphate diphosphohydrolase 2-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 21 samples with support for all annotated introns
ectonucleoside triphosphate diphosphohydrolase 2-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
ectonucleoside triphosphate diphosphohydrolase 2-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 17 Proteins, and 98% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 80% coverage of the annotated genomic feature by RNAseq alignments
apical endosomal glycoprotein-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
apical endosomal glycoprotein-like, transcript variant X2
apical endosomal glycoprotein-like isoform X2
apical endosomal glycoprotein-like isoform X1
Ral GEF with PH domain and SH3 binding motif 1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 97% coverage of the annotated genomic feature by RNAseq alignments
ras-specific guanine nucleotide-releasing factor RalGPS1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 EST, 27 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 18 samples with support for all annotated introns
uncharacterized LOC102689433, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
uncharacterized LOC102689433, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 93% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 71% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
LIM homeobox transcription factor 1, beta, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
LIM homeobox transcription factor 1, beta, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 16 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
LIM homeobox transcription factor 1, beta, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
LIM homeobox transcription factor 1-beta isoform X2
LIM homeobox transcription factor 1-beta isoform X1
LIM homeobox transcription factor 1-beta isoform X3
multivesicular body subunit 12B, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 18 samples with support for all annotated introns
multivesicular body subunit 12B, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
multivesicular body subunit 12B, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
multivesicular body subunit 12B isoform X2
multivesicular body subunit 12B isoform X1
multivesicular body subunit 12B isoform X3
multivesicular body subunit 12B, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
multivesicular body subunit 12B isoform X4
pre-B-cell leukemia homeobox 3, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 ESTs, 13 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
pre-B-cell leukemia homeobox 3, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 EST, 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
pre-B-cell leukemia homeobox 3, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 ESTs, 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
pre-B-cell leukemia homeobox 3, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 EST, 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
pre-B-cell leukemia transcription factor 3 isoform X4
pre-B-cell leukemia transcription factor 3 isoform X2
pre-B-cell leukemia transcription factor 3 isoform X3
pre-B-cell leukemia transcription factor 3 isoform X1
pre-B-cell leukemia homeobox 3, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 ESTs, 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
pre-B-cell leukemia homeobox 3, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 EST, 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
pre-B-cell leukemia transcription factor 3 isoform X6
pre-B-cell leukemia transcription factor 3 isoform X5
mitogen-activated protein kinase associated protein 1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 80% coverage of the annotated genomic feature by RNAseq alignments
target of rapamycin complex 2 subunit MAPKAP1
GTPase activating protein and VPS9 domains 1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
GTPase activating protein and VPS9 domains 1, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
GTPase activating protein and VPS9 domains 1, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
GTPase activating protein and VPS9 domains 1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
GTPase activating protein and VPS9 domains 1, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
GTPase activating protein and VPS9 domains 1, transcript variant X5
GTPase activating protein and VPS9 domains 1, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
GTPase-activating protein and VPS9 domain-containing protein 1 isoform X5
GTPase-activating protein and VPS9 domain-containing protein 1 isoform X4
GTPase-activating protein and VPS9 domain-containing protein 1 isoform X2
GTPase-activating protein and VPS9 domain-containing protein 1 isoform X1
GTPase-activating protein and VPS9 domain-containing protein 1 isoform X3
chromosome LG21 open reading frame, human C9orf172, transcript variant X1
chromosome LG21 open reading frame, human C9orf172, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
uncharacterized protein C9orf172 homolog
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 88% coverage of the annotated genomic feature by RNAseq alignments
TNF receptor-associated factor 2-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
TNF receptor-associated factor 2-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 16 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
TNF receptor-associated factor 2-like isoform X1
TNF receptor-associated factor 2-like isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
dual specificity testis-specific protein kinase 1-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
dual specificity testis-specific protein kinase 1-like, transcript variant X3
dual specificity testis-specific protein kinase 1-like, transcript variant X1
dual specificity testis-specific protein kinase 1-like, transcript variant X6
dual specificity testis-specific protein kinase 1-like, transcript variant X9
dual specificity testis-specific protein kinase 1-like, transcript variant X8
dual specificity testis-specific protein kinase 1-like, transcript variant X5
dual specificity testis-specific protein kinase 1-like, transcript variant X7
dual specificity testis-specific protein kinase 1-like, transcript variant X10
dual specificity testis-specific protein kinase 1-like, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
dual specificity testis-specific protein kinase 1-like
dipeptidyl-peptidase 7, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 20 samples with support for all annotated introns
dipeptidyl-peptidase 7, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 22 samples with support for all annotated introns
kelch-like protein 9, transcript variant X1
kelch-like protein 9, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 98% coverage of the annotated genomic feature by RNAseq alignments
endoplasmic reticulum mannosyl-oligosaccharide 1,2-alpha-mannosidase
collagen alpha-1(I) chain-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
collagen alpha-1(I) chain-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
collagen alpha-1(I) chain-like isoform X1
collagen alpha-1(I) chain-like isoform X2
collagen alpha-1(I) chain-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
collagen alpha-1(I) chain-like isoform X3
voltage-dependent N-type calcium channel subunit alpha-1B-like, transcript variant X22
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
voltage-dependent N-type calcium channel subunit alpha-1B-like, transcript variant X16
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
voltage-dependent N-type calcium channel subunit alpha-1B-like, transcript variant X20
voltage-dependent N-type calcium channel subunit alpha-1B-like, transcript variant X15
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
voltage-dependent N-type calcium channel subunit alpha-1B-like, transcript variant X21
voltage-dependent N-type calcium channel subunit alpha-1B-like, transcript variant X12
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
voltage-dependent N-type calcium channel subunit alpha-1B-like, transcript variant X8
voltage-dependent N-type calcium channel subunit alpha-1B-like, transcript variant X24
voltage-dependent N-type calcium channel subunit alpha-1B-like, transcript variant X23
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
voltage-dependent N-type calcium channel subunit alpha-1B-like, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
voltage-dependent N-type calcium channel subunit alpha-1B-like, transcript variant X19
voltage-dependent N-type calcium channel subunit alpha-1B-like, transcript variant X14
voltage-dependent N-type calcium channel subunit alpha-1B-like, transcript variant X13
voltage-dependent N-type calcium channel subunit alpha-1B-like, transcript variant X18
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
voltage-dependent N-type calcium channel subunit alpha-1B-like, transcript variant X11
voltage-dependent N-type calcium channel subunit alpha-1B-like, transcript variant X10
voltage-dependent N-type calcium channel subunit alpha-1B-like, transcript variant X4
voltage-dependent N-type calcium channel subunit alpha-1B-like, transcript variant X7
voltage-dependent N-type calcium channel subunit alpha-1B-like, transcript variant X5
voltage-dependent N-type calcium channel subunit alpha-1B-like, transcript variant X3
voltage-dependent N-type calcium channel subunit alpha-1B-like, transcript variant X9
voltage-dependent N-type calcium channel subunit alpha-1B-like, transcript variant X1
voltage-dependent N-type calcium channel subunit alpha-1B-like, transcript variant X2
voltage-dependent N-type calcium channel subunit alpha-1B-like isoform X22
voltage-dependent N-type calcium channel subunit alpha-1B-like isoform X16
voltage-dependent N-type calcium channel subunit alpha-1B-like isoform X20
voltage-dependent N-type calcium channel subunit alpha-1B-like isoform X15
voltage-dependent N-type calcium channel subunit alpha-1B-like isoform X21
voltage-dependent N-type calcium channel subunit alpha-1B-like isoform X12
voltage-dependent N-type calcium channel subunit alpha-1B-like isoform X8
voltage-dependent N-type calcium channel subunit alpha-1B-like isoform X24
voltage-dependent N-type calcium channel subunit alpha-1B-like isoform X23
voltage-dependent N-type calcium channel subunit alpha-1B-like isoform X6
voltage-dependent N-type calcium channel subunit alpha-1B-like isoform X19
voltage-dependent N-type calcium channel subunit alpha-1B-like isoform X14
voltage-dependent N-type calcium channel subunit alpha-1B-like isoform X13
voltage-dependent N-type calcium channel subunit alpha-1B-like isoform X18
voltage-dependent N-type calcium channel subunit alpha-1B-like isoform X11
voltage-dependent N-type calcium channel subunit alpha-1B-like isoform X10
voltage-dependent N-type calcium channel subunit alpha-1B-like isoform X4
voltage-dependent N-type calcium channel subunit alpha-1B-like isoform X7
voltage-dependent N-type calcium channel subunit alpha-1B-like isoform X5
voltage-dependent N-type calcium channel subunit alpha-1B-like isoform X3
voltage-dependent N-type calcium channel subunit alpha-1B-like isoform X9
voltage-dependent N-type calcium channel subunit alpha-1B-like isoform X1
voltage-dependent N-type calcium channel subunit alpha-1B-like isoform X2
voltage-dependent N-type calcium channel subunit alpha-1B-like, transcript variant X17
voltage-dependent N-type calcium channel subunit alpha-1B-like isoform X17
voltage-dependent P/Q-type calcium channel subunit alpha-1A-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 98% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
histone-lysine N-methyltransferase EHMT1-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 97% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
negative elongation factor complex member B
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 98% coverage of the annotated genomic feature by RNAseq alignments
ER degradation-enhancing alpha-mannosidase-like protein 3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 89% coverage of the annotated genomic feature by RNAseq alignments
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: substituted 1 base at 1 genomic stop codon; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: ER degradation-enhancing alpha-mannosidase-like protein 3
solute carrier family 31 (copper transporter), member 2, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
solute carrier family 31 (copper transporter), member 2, transcript variant X1
solute carrier family 31 (copper transporter), member 2, transcript variant X2
probable low affinity copper uptake protein 2 isoform X2
probable low affinity copper uptake protein 2 isoform X1
probable low affinity copper uptake protein 2 isoform X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 17 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 1 EST, 11 Proteins, and 97% coverage of the annotated genomic feature by RNAseq alignments
AT-hook-containing transcription factor-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
NADPH oxidase activator 1, transcript variant X4
NADPH oxidase activator 1, transcript variant X2
NADPH oxidase activator 1, transcript variant X3
NADPH oxidase activator 1, transcript variant X7
NADPH oxidase activator 1, transcript variant X5
NADPH oxidase activator 1, transcript variant X1
NADPH oxidase activator 1, transcript variant X6
neural proliferation, differentiation and control, 1
neural proliferation differentiation and control protein 1
POU domain, class 5, transcription factor 1-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
ATP binding cassette subfamily A member 2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 84% coverage of the annotated genomic feature by RNAseq alignments
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: substituted 2 bases at 2 genomic stop codons; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: ATP-binding cassette sub-family A member 2
chloride intracellular channel 3, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 35 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
chloride intracellular channel 3, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 34 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
chloride intracellular channel 3, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 34 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
chloride intracellular channel protein 3
chromosome LG21 open reading frame, human C9orf142, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 22 samples with support for all annotated introns
chromosome LG21 open reading frame, human C9orf142, transcript variant X1
diphthamide biosynthesis 7, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 21 samples with support for all annotated introns
diphthamide biosynthesis 7, transcript variant X1
diphthamide biosynthesis 7, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
mitochondrial ribosomal protein L41, transcript variant X1
mitochondrial ribosomal protein L41, transcript variant X3
mitochondrial ribosomal protein L41, transcript variant X2
39S ribosomal protein L41, mitochondrial
patatin like phospholipase domain containing 7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 ESTs, 9 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments
patatin-like phospholipase domain-containing protein 7
NMDA receptor synaptonuclear signaling and neuronal migration factor
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments
uncharacterized LOC102694444, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments
uncharacterized protein LOC102694444 isoform X2
uncharacterized LOC102694444, transcript variant X4
uncharacterized LOC102694444, transcript variant X3
uncharacterized LOC102694444, transcript variant X2
uncharacterized LOC102694444, transcript variant X5
uncharacterized LOC102694444, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 20 samples with support for all annotated introns
uncharacterized protein LOC102694444 isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
uncharacterized LOC102694640, transcript variant X3
uncharacterized LOC102694640, transcript variant X2
uncharacterized LOC102694640, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
uncharacterized LOC102694640, transcript variant X4
F-box and WD repeat domain containing 2, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
F-box and WD repeat domain containing 2, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 22 samples with support for all annotated introns
F-box/WD repeat-containing protein 2 isoform X3
F-box/WD repeat-containing protein 2 isoform X1
F-box and WD repeat domain containing 2, transcript variant X2
F-box/WD repeat-containing protein 2 isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 97% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 84% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 93% coverage of the annotated genomic feature by RNAseq alignments
ADAM metallopeptidase with thrombospondin type 1 motif 13
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 96% coverage of the annotated genomic feature by RNAseq alignments
A disintegrin and metalloproteinase with thrombospondin motifs 13
carnitine O-acetyltransferase, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 21 samples with support for all annotated introns
carnitine O-acetyltransferase, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
carnitine O-acetyltransferase isoform X1
carnitine O-acetyltransferase isoform X2
protein phosphatase 2A regulatory subunit 4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 EST, 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 22 samples with support for all annotated introns
serine/threonine-protein phosphatase 2A activator
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 ESTs, 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
immediate early response gene 5-like protein
N-terminal Xaa-Pro-Lys N-methyltransferase 1, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 18 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
N-terminal Xaa-Pro-Lys N-methyltransferase 1, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 18 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
N-terminal Xaa-Pro-Lys N-methyltransferase 1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 18 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
N-terminal Xaa-Pro-Lys N-methyltransferase 1 isoform X1
N-terminal Xaa-Pro-Lys N-methyltransferase 1, transcript variant X9
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 18 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
N-terminal Xaa-Pro-Lys N-methyltransferase 1 isoform X3
N-terminal Xaa-Pro-Lys N-methyltransferase 1, transcript variant X5
N-terminal Xaa-Pro-Lys N-methyltransferase 1 isoform X4
N-terminal Xaa-Pro-Lys N-methyltransferase 1, transcript variant X11
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 18 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
N-terminal Xaa-Pro-Lys N-methyltransferase 1, transcript variant X6
N-terminal Xaa-Pro-Lys N-methyltransferase 1 isoform X5
N-terminal Xaa-Pro-Lys N-methyltransferase 1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 18 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
N-terminal Xaa-Pro-Lys N-methyltransferase 1 isoform X2
N-terminal Xaa-Pro-Lys N-methyltransferase 1, transcript variant X8
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 18 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 20 samples with support for all annotated introns
N-terminal Xaa-Pro-Lys N-methyltransferase 1, transcript variant X12
N-terminal Xaa-Pro-Lys N-methyltransferase 1, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 18 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
N-terminal Xaa-Pro-Lys N-methyltransferase 1, transcript variant X10
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 18 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
N-terminal Xaa-Pro-Lys N-methyltransferase 1 isoform X6
ankyrin repeat and SOCS box containing 6
NADPH dependent diflavin oxidoreductase 1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 95% coverage of the annotated genomic feature by RNAseq alignments
NADPH-dependent diflavin oxidoreductase 1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 21 samples with support for all annotated introns
solute carrier family 2 (facilitated glucose transporter), member 8
solute carrier family 2, facilitated glucose transporter member 8
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
notch-regulated ankyrin repeat-containing protein
exonuclease mut-7 homolog, transcript variant X3
exonuclease mut-7 homolog, transcript variant X4
exonuclease mut-7 homolog, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
exonuclease mut-7 homolog, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 89% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
torsin family 4, member A, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
torsin family 4, member A, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
torsin family 4, member A, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 20 samples with support for all annotated introns
discoidin domain-containing receptor 2-like, transcript variant X2
discoidin domain-containing receptor 2-like, transcript variant X1
discoidin domain-containing receptor 2-like, transcript variant X3
discoidin domain-containing receptor 2-like isoform X1
discoidin domain-containing receptor 2-like isoform X2
epithelial discoidin domain-containing receptor 1-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 92% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 Proteins, and 80% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 108 mRNAs, 639 ESTs, 354 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 22 samples with support for all annotated introns
tubulin beta-4B chain, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 332 ESTs, 79 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 22 samples with support for all annotated introns
tubulin beta-4B chain, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 25 mRNAs, 620 ESTs, 341 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 22 samples with support for all annotated introns
family with sequence similarity 166 member A, transcript variant X2
family with sequence similarity 166 member A, transcript variant X1
family with sequence similarity 166 member A, transcript variant X3
bcl-2-related ovarian killer protein-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
bcl-2-related ovarian killer protein-like isoform X1
bcl-2-related ovarian killer protein-like, transcript variant X2
bcl-2-related ovarian killer protein-like isoform X2
uncharacterized LOC107079843, transcript variant X2
uncharacterized LOC107079843, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 18 samples with support for all annotated introns
LIM domain transcription factor LMO4-B-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 97% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 17 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
chromosome LG21 open reading frame, human C9orf43, transcript variant X3
uncharacterized protein C9orf43 homolog isoform X3
chromosome LG21 open reading frame, human C9orf43, transcript variant X2
chromosome LG21 open reading frame, human C9orf43, transcript variant X1
uncharacterized protein C9orf43 homolog isoform X2
uncharacterized protein C9orf43 homolog isoform X1
polymerase (DNA directed), epsilon 3, accessory subunit
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 EST, 13 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 22 samples with support for all annotated introns
leucine rich repeat and sterile alpha motif containing 1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 98% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 96% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 93% coverage of the annotated genomic feature by RNAseq alignments
solute carrier family 27 (fatty acid transporter), member 4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments
long-chain fatty acid transport protein 4
SWI5 homologous recombination repair protein, transcript variant X1
DNA repair protein SWI5 homolog isoform X1
SWI5 homologous recombination repair protein, transcript variant X2
DNA repair protein SWI5 homolog isoform X2
SWI5 homologous recombination repair protein, transcript variant X3
DNA repair protein SWI5 homolog isoform X3
transmembrane protein 8C, transcript variant X2
transmembrane protein 8C, transcript variant X7
transmembrane protein 8C, transcript variant X4
transmembrane protein 8C, transcript variant X6
transmembrane protein 8C, transcript variant X1
transmembrane protein 8C, transcript variant X3
transmembrane protein 8C, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 95% coverage of the annotated genomic feature by RNAseq alignments
family with sequence similarity 163 member B, transcript variant X2
family with sequence similarity 163 member B, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
dopamine beta-hydroxylase (dopamine beta-monooxygenase)
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 98% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 96% coverage of the annotated genomic feature by RNAseq alignments
cilia and flagella associated protein 157
uncharacterized protein C9orf117 homolog
cerebral endothelial cell adhesion molecule, transcript variant X3
cerebral endothelial cell adhesion molecule, transcript variant X2
cerebral endothelial cell adhesion molecule, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 28 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 17 samples with support for all annotated introns
probable inactive glycosyltransferase 25 family member 3 isoform X2
probable inactive glycosyltransferase 25 family member 3 isoform X1
probable inactive glycosyltransferase 25 family member 3 isoform X3
ubiquitin related modifier 1, transcript variant X2
ubiquitin related modifier 1, transcript variant X4
ubiquitin related modifier 1, transcript variant X1
ubiquitin related modifier 1, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 94% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
transfer RNA leucine (anticodon AAG); tRNA features were annotated by tRNAscan-SE; Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
spermatid perinuclear RNA binding protein, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
spermatid perinuclear RNA binding protein, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
spermatid perinuclear RNA binding protein, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
spermatid perinuclear RNA binding protein, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 17 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
spermatid perinuclear RNA-binding protein isoform X1
spermatid perinuclear RNA-binding protein isoform X2
uncharacterized LOC107079814, transcript variant X2
uncharacterized LOC107079814, transcript variant X1
RAB GTPase activating protein 1, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
RAB GTPase activating protein 1, transcript variant X7
RAB GTPase activating protein 1, transcript variant X2
RAB GTPase activating protein 1, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
RAB GTPase activating protein 1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 21 samples with support for all annotated introns
RAB GTPase activating protein 1, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 17 samples with support for all annotated introns
RAB GTPase activating protein 1, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
RAB GTPase activating protein 1, transcript variant X8
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
rab GTPase-activating protein 1 isoform X2
rab GTPase-activating protein 1 isoform X1
rab GTPase-activating protein 1 isoform X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
zinc finger and BTB domain-containing protein 26-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 20 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 37 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
NADH:ubiquinone oxidoreductase subunit A8
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 22 samples with support for all annotated introns
NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 8
MORN repeat containing 5, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
MORN repeat containing 5, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
MORN repeat-containing protein 5 isoform X1
MORN repeat-containing protein 5 isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 98% coverage of the annotated genomic feature by RNAseq alignments
mitochondrial ribosome recycling factor, transcript variant X1
mitochondrial ribosome recycling factor, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
mitochondrial ribosome recycling factor, transcript variant X3
ribosome-recycling factor, mitochondrial
prostaglandin-endoperoxide synthase 1 (prostaglandin G/H synthase and cyclooxygenase)
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 56 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
uncharacterized LOC107079840, transcript variant X2
uncharacterized LOC107079840, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 ESTs, 28 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 22 samples with support for all annotated introns
CDK5 regulatory subunit associated protein 2, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
CDK5 regulatory subunit associated protein 2, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
CDK5 regulatory subunit associated protein 2, transcript variant X5
CDK5 regulatory subunit associated protein 2, transcript variant X4
CDK5 regulatory subunit associated protein 2, transcript variant X1
CDK5 regulatory subunit associated protein 2, transcript variant X3
CDK5 regulatory subunit associated protein 2, transcript variant X2
CDK5 regulatory subunit-associated protein 2 isoform X4
CDK5 regulatory subunit-associated protein 2 isoform X6
CDK5 regulatory subunit-associated protein 2 isoform X3
CDK5 regulatory subunit-associated protein 2 isoform X5
CDK5 regulatory subunit-associated protein 2 isoform X1
CDK5 regulatory subunit-associated protein 2 isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments
peptidyl-prolyl cis-trans isomerase-like 3
3-oxoacyl-[acyl-carrier-protein] reductase FabG-like
collagen, type XXVII, alpha 1, transcript variant X4
collagen, type XXVII, alpha 1, transcript variant X1
collagen, type XXVII, alpha 1, transcript variant X2
collagen, type XXVII, alpha 1, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
collagen alpha-1(XXVII) chain isoform X4
collagen alpha-1(XXVII) chain isoform X1
collagen alpha-1(XXVII) chain isoform X2
collagen alpha-1(XXVII) chain isoform X3
26S proteasome non-ATPase regulatory subunit 5
uncharacterized LOC102685891, transcript variant X2
uncharacterized LOC102685891, transcript variant X1
uncharacterized protein LOC102685891 isoform X2
uncharacterized protein LOC102685891 isoform X1
putative UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase LOC100288842
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 26% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
potassium channel, sodium activated subfamily T, member 1, transcript variant X2
potassium channel, sodium activated subfamily T, member 1, transcript variant X7
potassium channel, sodium activated subfamily T, member 1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
potassium channel, sodium activated subfamily T, member 1, transcript variant X9
potassium channel, sodium activated subfamily T, member 1, transcript variant X4
potassium channel, sodium activated subfamily T, member 1, transcript variant X5
potassium channel, sodium activated subfamily T, member 1, transcript variant X11
potassium channel, sodium activated subfamily T, member 1, transcript variant X6
potassium channel, sodium activated subfamily T, member 1, transcript variant X12
potassium channel, sodium activated subfamily T, member 1, transcript variant X14
potassium channel, sodium activated subfamily T, member 1, transcript variant X3
potassium channel, sodium activated subfamily T, member 1, transcript variant X8
potassium channel, sodium activated subfamily T, member 1, transcript variant X10
potassium channel subfamily T member 1 isoform X1
potassium channel subfamily T member 1 isoform X3
potassium channel subfamily T member 1 isoform X9
potassium channel subfamily T member 1 isoform X4
potassium channel subfamily T member 1 isoform X5
potassium channel subfamily T member 1 isoform X11
potassium channel subfamily T member 1 isoform X2
potassium channel subfamily T member 1 isoform X6
potassium channel subfamily T member 1 isoform X8
potassium channel subfamily T member 1 isoform X12
potassium channel subfamily T member 1 isoform X10
potassium channel subfamily T member 1 isoform X14
potassium channel subfamily T member 1 isoform X7
potassium channel, sodium activated subfamily T, member 1, transcript variant X13
potassium channel, sodium activated subfamily T, member 1, transcript variant X15
potassium channel subfamily T member 1 isoform X13
potassium channel subfamily T member 1 isoform X15
calmodulin regulated spectrin associated protein 1, transcript variant X5
calmodulin regulated spectrin associated protein 1, transcript variant X3
calmodulin regulated spectrin associated protein 1, transcript variant X1
calmodulin regulated spectrin associated protein 1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
calmodulin regulated spectrin associated protein 1, transcript variant X9
calmodulin regulated spectrin associated protein 1, transcript variant X8
calmodulin regulated spectrin associated protein 1, transcript variant X6
calmodulin regulated spectrin associated protein 1, transcript variant X7
calmodulin regulated spectrin associated protein 1, transcript variant X11
calmodulin regulated spectrin associated protein 1, transcript variant X4
calmodulin regulated spectrin associated protein 1, transcript variant X12
calmodulin regulated spectrin associated protein 1, transcript variant X10
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
calmodulin regulated spectrin associated protein 1, transcript variant X13
calmodulin-regulated spectrin-associated protein 1 isoform X8
calmodulin-regulated spectrin-associated protein 1 isoform X5
calmodulin-regulated spectrin-associated protein 1 isoform X3
calmodulin-regulated spectrin-associated protein 1 isoform X4
calmodulin-regulated spectrin-associated protein 1 isoform X1
calmodulin-regulated spectrin-associated protein 1 isoform X9
calmodulin-regulated spectrin-associated protein 1 isoform X7
calmodulin-regulated spectrin-associated protein 1 isoform X2
calmodulin-regulated spectrin-associated protein 1 isoform X6
calmodulin-regulated spectrin-associated protein 1 isoform X10
UBA domain containing 1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 21 samples with support for all annotated introns
UBA domain containing 1, transcript variant X1
ubiquitin-associated domain-containing protein 1 isoform X2
ubiquitin-associated domain-containing protein 1 isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 29 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
neurogenic locus notch homolog protein 1
SEC16 homolog A, endoplasmic reticulum export factor, transcript variant X1
SEC16 homolog A, endoplasmic reticulum export factor, transcript variant X2
SEC16 homolog A, endoplasmic reticulum export factor, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
SEC16 homolog A, endoplasmic reticulum export factor, transcript variant X4
protein transport protein Sec16A isoform X1
protein transport protein Sec16A isoform X2
protein transport protein Sec16A isoform X3
protein transport protein Sec16A isoform X4
inositol polyphosphate-5-phosphatase E, transcript variant X1
inositol polyphosphate-5-phosphatase E, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
72 kDa inositol polyphosphate 5-phosphatase isoform X1
72 kDa inositol polyphosphate 5-phosphatase isoform X2
peptidase (mitochondrial processing) alpha
mitochondrial-processing peptidase subunit alpha
spermatogenesis and oogenesis specific basic helix-loop-helix 1
spermatogenesis- and oogenesis-specific basic helix-loop-helix-containing protein 1
calcium channel flower domain containing 1
solute carrier family 2 (facilitated glucose transporter), member 6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
solute carrier family 2, facilitated glucose transporter member 6
serine/threonine kinase-like domain containing 1, transcript variant X1
serine/threonine kinase-like domain containing 1, transcript variant X2
serine/threonine kinase-like domain containing 1, transcript variant X3
serine/threonine kinase-like domain-containing protein STKLD1 isoform X1
serine/threonine kinase-like domain-containing protein STKLD1 isoform X2
serine/threonine kinase-like domain-containing protein STKLD1 isoform X3
formin binding protein 1, transcript variant X8
formin binding protein 1, transcript variant X10
formin binding protein 1, transcript variant X13
formin binding protein 1, transcript variant X5
formin binding protein 1, transcript variant X1
formin binding protein 1, transcript variant X11
formin binding protein 1, transcript variant X3
formin binding protein 1, transcript variant X12
formin binding protein 1, transcript variant X22
formin binding protein 1, transcript variant X23
formin binding protein 1, transcript variant X2
formin binding protein 1, transcript variant X15
formin binding protein 1, transcript variant X17
formin binding protein 1, transcript variant X24
formin binding protein 1, transcript variant X6
formin binding protein 1, transcript variant X7
formin binding protein 1, transcript variant X14
formin binding protein 1, transcript variant X16
formin binding protein 1, transcript variant X19
formin binding protein 1, transcript variant X25
formin binding protein 1, transcript variant X26
formin binding protein 1, transcript variant X29
formin binding protein 1, transcript variant X20
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
formin binding protein 1, transcript variant X21
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
formin binding protein 1, transcript variant X18
formin binding protein 1, transcript variant X27
formin binding protein 1, transcript variant X28
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
formin binding protein 1, transcript variant X9
formin binding protein 1, transcript variant X4
torsin family 1, member B (torsin B), transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 20 samples with support for all annotated introns
torsin family 1, member B (torsin B), transcript variant X2
EGF-like-domain, multiple 7, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
EGF-like-domain, multiple 7, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 20 samples with support for all annotated introns
EGF-like-domain, multiple 7, transcript variant X2
1-acylglycerol-3-phosphate O-acyltransferase 2
1-acyl-sn-glycerol-3-phosphate acyltransferase beta
family with sequence similarity 69 member B
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 22 samples with support for all annotated introns
chromosome LG21 open reading frame, human C9orf116
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
protein phosphatase 1 regulatory subunit 26, transcript variant X3
protein phosphatase 1 regulatory subunit 26 isoform X3
protein phosphatase 1 regulatory subunit 26, transcript variant X2
protein phosphatase 1 regulatory subunit 26 isoform X2
protein phosphatase 1 regulatory subunit 26, transcript variant X4
protein phosphatase 1 regulatory subunit 26, transcript variant X1
protein phosphatase 1 regulatory subunit 26 isoform X4
protein phosphatase 1 regulatory subunit 26 isoform X1
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: inserted 1 base in 1 codon; deleted 4 bases in 2 codons; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 Proteins
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: inserted 1 base in 1 codon; deleted 4 bases in 2 codons; substituted 1 base at 1 genomic stop codon; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: toll-like receptor 4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 101 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
bone morphogenetic protein/retinoic acid inducible neural-specific 1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 ESTs, 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
BMP/retinoic acid-inducible neural-specific protein 1
adenylate kinase isoenzyme 1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 23 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
adenylate kinase isoenzyme 1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 24 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 20 samples with support for all annotated introns
adenylate kinase isoenzyme 1, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 23 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
adenylate kinase isoenzyme 1, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 22 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 22 samples with support for all annotated introns
adenylate kinase isoenzyme 1, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 22 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 18 samples with support for all annotated introns
adenylate kinase isoenzyme 1, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 22 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
G-protein signaling modulator 1, transcript variant X1
G-protein signaling modulator 1, transcript variant X2
G-protein signaling modulator 1, transcript variant X4
G-protein signaling modulator 1, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
G-protein-signaling modulator 1 isoform X1
G-protein-signaling modulator 1 isoform X2
G-protein-signaling modulator 1 isoform X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 98% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
chromosome LG21 open reading frame, human C9orf69, transcript variant X6
chromosome LG21 open reading frame, human C9orf69, transcript variant X1
chromosome LG21 open reading frame, human C9orf69, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
chromosome LG21 open reading frame, human C9orf69, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
chromosome LG21 open reading frame, human C9orf69, transcript variant X5
chromosome LG21 open reading frame, human C9orf69, transcript variant X3
NACC family member 2, BEN and BTB (POZ) domain containing, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 17 samples with support for all annotated introns
NACC family member 2, BEN and BTB (POZ) domain containing, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
uncharacterized LOC107079859, transcript variant X3
uncharacterized LOC107079859, transcript variant X2
uncharacterized LOC107079859, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
DAB2 interacting protein, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
DAB2 interacting protein, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
DAB2 interacting protein, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
disabled homolog 2-interacting protein isoform X1
disabled homolog 2-interacting protein isoform X3
disabled homolog 2-interacting protein isoform X2
DAB2 interacting protein, transcript variant X5
disabled homolog 2-interacting protein isoform X5
DAB2 interacting protein, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
DAB2 interacting protein, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
disabled homolog 2-interacting protein isoform X4
DAB2 interacting protein, transcript variant X7
disabled homolog 2-interacting protein isoform X6
DAB2 interacting protein, transcript variant X9
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
DAB2 interacting protein, transcript variant X8
disabled homolog 2-interacting protein isoform X7
disabled homolog 2-interacting protein isoform X8
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 18 samples with support for all annotated introns
carboxyl-terminal PDZ ligand of neuronal nitric oxide synthase protein-like, transcript variant X1
carboxyl-terminal PDZ ligand of neuronal nitric oxide synthase protein-like, transcript variant X2
carboxyl-terminal PDZ ligand of neuronal nitric oxide synthase protein-like, transcript variant X3
carboxyl-terminal PDZ ligand of neuronal nitric oxide synthase protein-like, transcript variant X4
carboxyl-terminal PDZ ligand of neuronal nitric oxide synthase protein-like isoform X1
carboxyl-terminal PDZ ligand of neuronal nitric oxide synthase protein-like isoform X2
GTPase activating Rap/RanGAP domain-like 3, transcript variant X1
GTPase activating Rap/RanGAP domain-like 3, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
GTPase-activating Rap/Ran-GAP domain-like protein 3 isoform X1
GTPase-activating Rap/Ran-GAP domain-like protein 3 isoform X4
GTPase activating Rap/RanGAP domain-like 3, transcript variant X2
GTPase activating Rap/RanGAP domain-like 3, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
GTPase-activating Rap/Ran-GAP domain-like protein 3 isoform X2
GTPase-activating Rap/Ran-GAP domain-like protein 3 isoform X3
paired related homeobox 2, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 18 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
paired related homeobox 2, transcript variant X2
paired mesoderm homeobox protein 2 isoform X1
paired mesoderm homeobox protein 2 isoform X2
ubiquitin specific peptidase 20, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 EST, 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 18 samples with support for all annotated introns
ubiquitin specific peptidase 20, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 EST, 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
ubiquitin specific peptidase 20, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 EST, 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
ubiquitin carboxyl-terminal hydrolase 20 isoform X2
ubiquitin carboxyl-terminal hydrolase 20 isoform X1
chromosome LG21 open reading frame, human C9orf78
cysteine conjugate-beta lyase, cytoplasmic, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
cysteine conjugate-beta lyase, cytoplasmic, transcript variant X1
cysteine conjugate-beta lyase, cytoplasmic, transcript variant X5
kynurenine--oxoglutarate transaminase 1 isoform X1
kynurenine--oxoglutarate transaminase 1 isoform X3
cysteine conjugate-beta lyase, cytoplasmic, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
cysteine conjugate-beta lyase, cytoplasmic, transcript variant X2
kynurenine--oxoglutarate transaminase 1 isoform X2
chromosome LG21 open reading frame, human C9orf114
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 17 samples with support for all annotated introns
putative methyltransferase C9orf114 homolog
endonuclease G, mitochondrial isoform X1
endonuclease G, mitochondrial isoform X2
endonuclease G, mitochondrial isoform X3
family with sequence similarity 73 member B, transcript variant X1
globoside alpha-1,3-N-acetylgalactosaminyltransferase 1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
ST6 (alpha-N-acetyl-neuraminyl-2,3-beta-galactosyl-1, 3)-N-acetylgalactosaminide alpha-2,6-sialyltransferase 6, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase 6 isoform X1
ST6 (alpha-N-acetyl-neuraminyl-2,3-beta-galactosyl-1, 3)-N-acetylgalactosaminide alpha-2,6-sialyltransferase 6, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 17 samples with support for all annotated introns
ST6 (alpha-N-acetyl-neuraminyl-2,3-beta-galactosyl-1, 3)-N-acetylgalactosaminide alpha-2,6-sialyltransferase 6, transcript variant X3
alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase 6 isoform X3
ST6 (alpha-N-acetyl-neuraminyl-2,3-beta-galactosyl-1, 3)-N-acetylgalactosaminide alpha-2,6-sialyltransferase 6, transcript variant X4
alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase 6 isoform X2
alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase 6 isoform X4
ST6 (alpha-N-acetyl-neuraminyl-2,3-beta-galactosyl-1, 3)-N-acetylgalactosaminide alpha-2,6-sialyltransferase 4, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 19 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
ST6 (alpha-N-acetyl-neuraminyl-2,3-beta-galactosyl-1, 3)-N-acetylgalactosaminide alpha-2,6-sialyltransferase 4, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 19 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
ST6 (alpha-N-acetyl-neuraminyl-2,3-beta-galactosyl-1, 3)-N-acetylgalactosaminide alpha-2,6-sialyltransferase 4, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 19 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
alpha-N-acetyl-neuraminyl-2,3-beta-galactosyl-1, 3-N-acetyl-galactosaminide alpha-2,6-sialyltransferase
family with sequence similarity 73 member B, transcript variant X2
family with sequence similarity 73 member B, transcript variant X3
mediator of RNA polymerase II transcription subunit 27
Rap guanine nucleotide exchange factor 1, transcript variant X3
Rap guanine nucleotide exchange factor 1, transcript variant X1
Rap guanine nucleotide exchange factor 1, transcript variant X2
Rap guanine nucleotide exchange factor 1, transcript variant X4
Rap guanine nucleotide exchange factor 1, transcript variant X5
Rap guanine nucleotide exchange factor 1, transcript variant X6
Rap guanine nucleotide exchange factor 1, transcript variant X12
Rap guanine nucleotide exchange factor 1, transcript variant X7
Rap guanine nucleotide exchange factor 1, transcript variant X11
Rap guanine nucleotide exchange factor 1, transcript variant X8
Rap guanine nucleotide exchange factor 1, transcript variant X9
Rap guanine nucleotide exchange factor 1, transcript variant X10
rap guanine nucleotide exchange factor 1 isoform X1
rap guanine nucleotide exchange factor 1 isoform X2
rap guanine nucleotide exchange factor 1 isoform X4
rap guanine nucleotide exchange factor 1 isoform X5
rap guanine nucleotide exchange factor 1 isoform X6
rap guanine nucleotide exchange factor 1 isoform X12
rap guanine nucleotide exchange factor 1 isoform X7
rap guanine nucleotide exchange factor 1 isoform X11
rap guanine nucleotide exchange factor 1 isoform X8
rap guanine nucleotide exchange factor 1 isoform X9
rap guanine nucleotide exchange factor 1 isoform X10
rap guanine nucleotide exchange factor 1 isoform X3
nucleoporin 188kDa, transcript variant X1
nucleoporin 188kDa, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
nucleoporin 188kDa, transcript variant X2
phytanoyl-CoA dioxygenase domain containing 1, transcript variant X1
phytanoyl-CoA dioxygenase domain containing 1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 18 samples with support for all annotated introns
phytanoyl-CoA dioxygenase domain-containing protein 1 isoform X2
phytanoyl-CoA dioxygenase domain-containing protein 1 isoform X1
leucine-rich repeat containing 8 family member A, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 28 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
leucine-rich repeat containing 8 family member A, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 28 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
leucine-rich repeat containing 8 family member A, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 28 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 21 samples with support for all annotated introns
leucine-rich repeat containing 8 family member A, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 28 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
leucine-rich repeat containing 8 family member A, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 28 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
volume-regulated anion channel subunit LRRC8A
serologically defined colon cancer antigen 3
small nuclear RNA activating complex polypeptide 4
snRNA-activating protein complex subunit 4
caspase recruitment domain family member 9, transcript variant X1
caspase recruitment domain family member 9, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
caspase recruitment domain family member 9, transcript variant X2
caspase recruitment domain family member 9, transcript variant X4
caspase recruitment domain-containing protein 9 isoform X1
caspase recruitment domain-containing protein 9 isoform X3
caspase recruitment domain-containing protein 9 isoform X2
caspase recruitment domain-containing protein 9 isoform X4
caspase recruitment domain family member 9, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
caspase recruitment domain-containing protein 9 isoform X5
DNL-type zinc finger, transcript variant X2
DNL-type zinc finger, transcript variant X1
uncharacterized LOC107079864, transcript variant X1
uncharacterized LOC107079864, transcript variant X2
uncharacterized LOC107079864, transcript variant X3
uncharacterized protein LOC107079864 isoform X1
uncharacterized protein LOC107079864 isoform X2
uncharacterized protein LOC107079864 isoform X3
coiled-coil domain containing 180, transcript variant X1
coiled-coil domain containing 180, transcript variant X2
coiled-coil domain containing 180, transcript variant X3
coiled-coil domain-containing protein 180 isoform X1
coiled-coil domain-containing protein 180 isoform X2
vav guanine nucleotide exchange factor 2, transcript variant X7
vav guanine nucleotide exchange factor 2, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
vav guanine nucleotide exchange factor 2, transcript variant X2
vav guanine nucleotide exchange factor 2, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
vav guanine nucleotide exchange factor 2, transcript variant X1
vav guanine nucleotide exchange factor 2, transcript variant X5
vav guanine nucleotide exchange factor 2, transcript variant X6
guanine nucleotide exchange factor VAV2 isoform X7
guanine nucleotide exchange factor VAV2 isoform X4
guanine nucleotide exchange factor VAV2 isoform X2
guanine nucleotide exchange factor VAV2 isoform X3
guanine nucleotide exchange factor VAV2 isoform X5
guanine nucleotide exchange factor VAV2 isoform X6
guanine nucleotide exchange factor VAV2 isoform X1
bromodomain containing 3, transcript variant X2
bromodomain containing 3, transcript variant X7
bromodomain containing 3, transcript variant X6
bromodomain containing 3, transcript variant X1
bromodomain containing 3, transcript variant X3
bromodomain containing 3, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
bromodomain containing 3, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
bromodomain containing 3, transcript variant X8
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
bromodomain-containing protein 3 isoform X8
bromodomain-containing protein 3 isoform X5
bromodomain-containing protein 3 isoform X4
bromodomain-containing protein 3 isoform X3
bromodomain-containing protein 3 isoform X7
bromodomain-containing protein 3 isoform X6
bromodomain-containing protein 3 isoform X2
bromodomain-containing protein 3 isoform X1
WD repeat domain 5, transcript variant X1
WD repeat domain 5, transcript variant X3
WD repeat domain 5, transcript variant X2
WD repeat domain 5, transcript variant X4
retinoid X receptor alpha, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 62 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
retinoid X receptor alpha, transcript variant X1
retinoid X receptor alpha, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
retinoic acid receptor RXR-alpha isoform X2
retinoic acid receptor RXR-alpha isoform X1
retinoic acid receptor RXR-alpha isoform X3
D-galactonate transporter-like, transcript variant X3
D-galactonate transporter-like, transcript variant X1
D-galactonate transporter-like, transcript variant X2
D-galactonate transporter-like isoform X2
D-galactonate transporter-like isoform X1
collagen alpha-1(V) chain-like, transcript variant X4
collagen alpha-1(V) chain-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
collagen alpha-1(V) chain-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
collagen alpha-1(V) chain-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
collagen alpha-1(V) chain-like isoform X1
collagen alpha-1(V) chain-like isoform X2
collagen alpha-1(V) chain-like isoform X4
collagen alpha-1(V) chain-like isoform X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
pregnancy-associated plasma protein A, pappalysin 1, transcript variant X1
pregnancy-associated plasma protein A, pappalysin 1, transcript variant X2
uncharacterized LOC107079872, transcript variant X2
uncharacterized LOC107079872, transcript variant X1
uncharacterized LOC107079872, transcript variant X9
uncharacterized LOC107079872, transcript variant X7
uncharacterized LOC107079872, transcript variant X6
uncharacterized LOC107079872, transcript variant X4
uncharacterized LOC107079872, transcript variant X3
uncharacterized LOC107079872, transcript variant X5
uncharacterized LOC107079872, transcript variant X8
uncharacterized protein LOC107079872 isoform X2
uncharacterized protein LOC107079872 isoform X1
zinc finger protein 618, transcript variant X2
zinc finger protein 618, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 EST, 48 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
P2Y purinoceptor 4-like, transcript variant X1
P2Y purinoceptor 4-like, transcript variant X5
P2Y purinoceptor 4-like, transcript variant X2
P2Y purinoceptor 4-like, transcript variant X4
P2Y purinoceptor 4-like, transcript variant X3
uncharacterized LOC107079875, transcript variant X2
uncharacterized LOC107079875, transcript variant X1
uncharacterized protein LOC107079875 isoform X2
uncharacterized protein LOC107079875 isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 99% coverage of the annotated genomic feature by RNAseq alignments
multiple epidermal growth factor-like domains protein 9
tumor necrosis factor superfamily member 15, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 45 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
tumor necrosis factor superfamily member 15, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 45 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 20 samples with support for all annotated introns
tumor necrosis factor ligand superfamily member 15
endothelial differentiation-related factor 1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 28 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 22 samples with support for all annotated introns
endothelial differentiation-related factor 1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 22 samples with support for all annotated introns
endothelial differentiation-related factor 1 isoform X1
endothelial differentiation-related factor 1 isoform X2
chromosome LG21 open reading frame, human C9orf16
CDKN1A interacting zinc finger protein 1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 20 samples with support for all annotated introns
cip1-interacting zinc finger protein-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 88% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 EST, 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 EST, 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 EST, 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 EST, 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 EST, 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 EST, 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 EST, 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 EST, 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 EST, 2 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 mRNAs, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
HAUS augmin like complex subunit 4, transcript variant X4
HAUS augmin like complex subunit 4, transcript variant X1
HAUS augmin like complex subunit 4, transcript variant X3
HAUS augmin like complex subunit 4, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 21 samples with support for all annotated introns
HAUS augmin like complex subunit 4, transcript variant X2
HAUS augmin-like complex subunit 4 isoform X2
HAUS augmin-like complex subunit 4 isoform X1
heat shock protein family A (Hsp70) member 5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 mRNAs, 53 ESTs, 274 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 22 samples with support for all annotated introns
Rab9 effector protein with kelch motifs, transcript variant X6
Rab9 effector protein with kelch motifs, transcript variant X5
Rab9 effector protein with kelch motifs, transcript variant X7
Rab9 effector protein with kelch motifs, transcript variant X9
Rab9 effector protein with kelch motifs, transcript variant X8
Rab9 effector protein with kelch motifs, transcript variant X1
Rab9 effector protein with kelch motifs, transcript variant X4
Rab9 effector protein with kelch motifs, transcript variant X3
Rab9 effector protein with kelch motifs, transcript variant X2
rab9 effector protein with kelch motifs isoform X3
rab9 effector protein with kelch motifs isoform X2
rab9 effector protein with kelch motifs isoform X1
protein phosphatase 6, catalytic subunit
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 18 ESTs, 52 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
serine/threonine-protein phosphatase 6 catalytic subunit
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 98% coverage of the annotated genomic feature by RNAseq alignments
actin related protein 2/3 complex subunit 5-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 19 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 22 samples with support for all annotated introns
actin-related protein 2/3 complex subunit 5-like protein
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 mRNAs, 120 ESTs, 29 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 22 samples with support for all annotated introns
WD repeat domain 38, transcript variant X2
WD repeat domain 38, transcript variant X1
WD repeat-containing protein 38 isoform X2
WD repeat-containing protein 38 isoform X1
uncharacterized LOC107079879, transcript variant X3
uncharacterized LOC107079879, transcript variant X2
uncharacterized LOC107079879, transcript variant X1
olfactomedin like 2A, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 EST, 13 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
olfactomedin like 2A, transcript variant X2
nuclear receptor subfamily 6 group A member 1, transcript variant X1
nuclear receptor subfamily 6 group A member 1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
nuclear receptor subfamily 6 group A member 1, transcript variant X3
nuclear receptor subfamily 6 group A member 1, transcript variant X4
nuclear receptor subfamily 6 group A member 1 isoform X1
nuclear receptor subfamily 6 group A member 1 isoform X2
nuclear receptor subfamily 6 group A member 1 isoform X3
nuclear receptor subfamily 6 group A member 1 isoform X4
nuclear receptor subfamily 6 group A member 1, transcript variant X6
nuclear receptor subfamily 6 group A member 1 isoform X6
nuclear receptor subfamily 6 group A member 1, transcript variant X5
nuclear receptor subfamily 6 group A member 1 isoform X5
uncharacterized LOC107079877, transcript variant X2
uncharacterized LOC107079877, transcript variant X1
nuclear receptor subfamily 5 group A member 1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 66 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
nuclear receptor subfamily 5 group A member 1, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 51 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
nuclear receptor subfamily 5 group A member 1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 66 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
adhesion G protein-coupled receptor D2, transcript variant X2
adhesion G protein-coupled receptor D2, transcript variant X3
adhesion G protein-coupled receptor D2, transcript variant X1
adhesion G protein-coupled receptor D2, transcript variant X4
kinesin-like protein KIF14, transcript variant X4
kinesin-like protein KIF14, transcript variant X3
kinesin-like protein KIF14, transcript variant X2
kinesin-like protein KIF14, transcript variant X1
kinesin-like protein KIF14, transcript variant X5
kinesin-like protein KIF14, transcript variant X6
uncharacterized protein LOC107079869 isoform X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 89% coverage of the annotated genomic feature by RNAseq alignments
proteasome subunit beta 7, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
proteasome subunit beta 7, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 38 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 22 samples with support for all annotated introns
proteasome subunit beta type-7 isoform X1
proteasome subunit beta type-7 isoform X2
NIMA-related kinase 6, transcript variant X2
NIMA-related kinase 6, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
NIMA-related kinase 6, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 17 samples with support for all annotated introns
serine/threonine-protein kinase Nek6 isoform X3
serine/threonine-protein kinase Nek6 isoform X1
serine/threonine-protein kinase Nek6 isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 ESTs, 9 Proteins, and 92% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 97% coverage of the annotated genomic feature by RNAseq alignments
folylpolyglutamate synthase, mitochondrial
uncharacterized LOC107079868, transcript variant X2
uncharacterized LOC107079868, transcript variant X1
uncharacterized LOC107079868, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 1 EST, 18 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 22 samples with support for all annotated introns
argininosuccinate synthase 1, transcript variant X2
argininosuccinate synthase 1, transcript variant X1
argininosuccinate synthase 1, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 17 samples with support for all annotated introns
far upstream element (FUSE) binding protein 3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 95% coverage of the annotated genomic feature by RNAseq alignments
LOW QUALITY PROTEIN: far upstream element-binding protein 3
PR domain containing 12, transcript variant X1
PR domain containing 12, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
PR domain zinc finger protein 12 isoform X1
PR domain zinc finger protein 12 isoform X2
tyrosine-protein kinase ABL1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 ESTs, 53 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 18 samples with support for all annotated introns
tyrosine-protein kinase ABL1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 EST, 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
pyroglutamylated RFamide peptide, transcript variant X2
pyroglutamylated RFamide peptide, transcript variant X3
pyroglutamylated RFamide peptide, transcript variant X1
RAB14, member RAS oncogene family, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 27 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 22 samples with support for all annotated introns
RAB14, member RAS oncogene family, transcript variant X2
RAB14, member RAS oncogene family, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 27 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
RAB14, member RAS oncogene family, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 27 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 19 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 40 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 22 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 18 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 17 samples with support for all annotated introns
erythrocyte band 7 integral membrane protein isoform X2
erythrocyte band 7 integral membrane protein isoform X1
transcription termination factor, RNA polymerase I
cilia and flagella associated protein 77
uncharacterized protein C9orf171 homolog
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
DEAD (Asp-Glu-Ala-Asp) box polypeptide 31
probable ATP-dependent RNA helicase DDX31
general transcription factor IIIC subunit 4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 21 samples with support for all annotated introns
general transcription factor 3C polypeptide 4
adenylate kinase 8, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
adenylate kinase 8, transcript variant X4
adenylate kinase 8, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
adenylate kinase 8, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
adenylate kinase 8, transcript variant X5
chromosome LG21 open reading frame, human C9orf9, transcript variant X2
chromosome LG21 open reading frame, human C9orf9, transcript variant X1
uncharacterized protein C9orf9 homolog isoform X1
uncharacterized protein C9orf9 homolog isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
growth factor independent 1B transcription repressor
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 EST, 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
general transcription factor IIIC subunit 5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 20 samples with support for all annotated introns
general transcription factor 3C polypeptide 5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 26 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
ral guanine nucleotide dissociation stimulator, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
ral guanine nucleotide dissociation stimulator, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
ral guanine nucleotide dissociation stimulator, transcript variant X4
ral guanine nucleotide dissociation stimulator, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 18 samples with support for all annotated introns
ral guanine nucleotide dissociation stimulator, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 18 samples with support for all annotated introns
ral guanine nucleotide dissociation stimulator isoform X1
ral guanine nucleotide dissociation stimulator isoform X2
ral guanine nucleotide dissociation stimulator isoform X4
ral guanine nucleotide dissociation stimulator isoform X5
ral guanine nucleotide dissociation stimulator isoform X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 ESTs, 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 17 samples with support for all annotated introns
outer dense fiber of sperm tails 2, transcript variant X2
outer dense fiber of sperm tails 2, transcript variant X3
outer dense fiber of sperm tails 2, transcript variant X4
outer dense fiber of sperm tails 2, transcript variant X1
outer dense fiber of sperm tails 2, transcript variant X5
outer dense fiber of sperm tails 2, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
outer dense fiber of sperm tails 2, transcript variant X7
spectrin, alpha, non-erythrocytic 1, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 34 ESTs, 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
spectrin, alpha, non-erythrocytic 1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 34 ESTs, 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
spectrin, alpha, non-erythrocytic 1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 34 ESTs, 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
spectrin, alpha, non-erythrocytic 1, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 55 ESTs, 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
spectrin, alpha, non-erythrocytic 1, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 30 ESTs, 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
spectrin, alpha, non-erythrocytic 1, transcript variant X8
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 51 ESTs, 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
spectrin, alpha, non-erythrocytic 1, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 34 ESTs, 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
spectrin, alpha, non-erythrocytic 1, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 35 ESTs, 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
spectrin, alpha, non-erythrocytic 1, transcript variant X9
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 56 ESTs, 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
spectrin, alpha, non-erythrocytic 1, transcript variant X10
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 52 ESTs, 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
spectrin alpha chain, non-erythrocytic 1 isoform X1
spectrin alpha chain, non-erythrocytic 1 isoform X6
spectrin alpha chain, non-erythrocytic 1 isoform X3
spectrin alpha chain, non-erythrocytic 1 isoform X7
spectrin alpha chain, non-erythrocytic 1 isoform X4
spectrin alpha chain, non-erythrocytic 1 isoform X5
spectrin alpha chain, non-erythrocytic 1 isoform X8
spectrin alpha chain, non-erythrocytic 1 isoform X9
spectrin alpha chain, non-erythrocytic 1 isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 5 ESTs, 19 Proteins, and 96% coverage of the annotated genomic feature by RNAseq alignments
protein kinase N3, transcript variant X1
protein kinase N3, transcript variant X2
UDP-N-acetylhexosamine pyrophosphorylase-like protein 1
amiloride-sensitive sodium channel subunit gamma-like, transcript variant X5
amiloride-sensitive sodium channel subunit gamma-like isoform X5
amiloride-sensitive sodium channel subunit gamma-like, transcript variant X2
amiloride-sensitive sodium channel subunit gamma-like, transcript variant X3
amiloride-sensitive sodium channel subunit gamma-like, transcript variant X1
amiloride-sensitive sodium channel subunit gamma-like isoform X3
amiloride-sensitive sodium channel subunit gamma-like isoform X2
amiloride-sensitive sodium channel subunit gamma-like isoform X1
amiloride-sensitive sodium channel subunit gamma-like, transcript variant X4
amiloride-sensitive sodium channel subunit gamma-like isoform X4
solute carrier family 25 (mitochondrial carrier; phosphate carrier), member 25, transcript variant X1
solute carrier family 25 (mitochondrial carrier; phosphate carrier), member 25, transcript variant X2
solute carrier family 25 (mitochondrial carrier; phosphate carrier), member 25, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
solute carrier family 25 (mitochondrial carrier; phosphate carrier), member 25, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
solute carrier family 25 (mitochondrial carrier; phosphate carrier), member 25, transcript variant X5
solute carrier family 25 (mitochondrial carrier; phosphate carrier), member 25, transcript variant X6
solute carrier family 25 (mitochondrial carrier; phosphate carrier), member 25, transcript variant X7
calcium-binding mitochondrial carrier protein SCaMC-2 isoform X4
calcium-binding mitochondrial carrier protein SCaMC-2 isoform X2
calcium-binding mitochondrial carrier protein SCaMC-2 isoform X3
calcium-binding mitochondrial carrier protein SCaMC-2 isoform X1
calcium-binding mitochondrial carrier protein SCaMC-2 isoform X5
calcium-binding mitochondrial carrier protein SCaMC-2 isoform X7
calcium-binding mitochondrial carrier protein SCaMC-2 isoform X6
family with sequence similarity 102 member A
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 96% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
dolichyl-phosphate mannosyltransferase polypeptide 2, regulatory subunit
dolichol phosphate-mannose biosynthesis regulatory protein
phosphatidylinositol-4-phosphate 5-kinase-like 1, transcript variant X1
phosphatidylinositol-4-phosphate 5-kinase-like 1, transcript variant X2
phosphatidylinositol 4-phosphate 5-kinase-like protein 1 isoform X1
phosphatidylinositol 4-phosphate 5-kinase-like protein 1 isoform X2
SH3-domain GRB2-like endophilin B2, transcript variant X1
SH3-domain GRB2-like endophilin B2, transcript variant X4
SH3-domain GRB2-like endophilin B2, transcript variant X8
SH3-domain GRB2-like endophilin B2, transcript variant X3
SH3-domain GRB2-like endophilin B2, transcript variant X7
SH3-domain GRB2-like endophilin B2, transcript variant X9
SH3-domain GRB2-like endophilin B2, transcript variant X2
SH3-domain GRB2-like endophilin B2, transcript variant X5
SH3-domain GRB2-like endophilin B2, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 19 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
SH3-domain GRB2-like endophilin B2, transcript variant X10
SH3-domain GRB2-like endophilin B2, transcript variant X11
leucine-rich repeat extensin-like protein 3, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 17 samples with support for all annotated introns
leucine-rich repeat extensin-like protein 3, transcript variant X2
leucine-rich repeat extensin-like protein 3
protein-O-mannosyltransferase 1, transcript variant X2
protein-O-mannosyltransferase 1, transcript variant X1
protein-O-mannosyltransferase 1, transcript variant X3
protein O-mannosyl-transferase 1 isoform X2
protein O-mannosyl-transferase 1 isoform X1
proline-rich coiled-coil 2B, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 ESTs, 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
proline-rich coiled-coil 2B, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 ESTs, 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 18 samples with support for all annotated introns
proline-rich coiled-coil 2B, transcript variant X8
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 ESTs, 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
proline-rich coiled-coil 2B, transcript variant X7
proline-rich coiled-coil 2B, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 ESTs, 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
proline-rich coiled-coil 2B, transcript variant X9
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 ESTs, 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
proline-rich coiled-coil 2B, transcript variant X10
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 ESTs, 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 20 samples with support for all annotated introns
proline-rich coiled-coil 2B, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 ESTs, 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 20 samples with support for all annotated introns
proline-rich coiled-coil 2B, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 ESTs, 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
proline-rich coiled-coil 2B, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
probable lipid phosphate phosphatase PPAPDC3
family with sequence similarity 78 member A
nucleoporin 214kDa, transcript variant X4
nuclear pore complex protein Nup214 isoform X4
nucleoporin 214kDa, transcript variant X3
nucleoporin 214kDa, transcript variant X1
nucleoporin 214kDa, transcript variant X2
nuclear pore complex protein Nup214 isoform X3
nuclear pore complex protein Nup214 isoform X2
nuclear pore complex protein Nup214 isoform X1
nucleoporin 214kDa, transcript variant X5
nuclear pore complex protein Nup214 isoform X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 23 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 18 samples with support for all annotated introns
uncharacterized LOC107079889, transcript variant X1
uncharacterized protein LOC107079889 isoform X1
uncharacterized LOC107079889, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
uncharacterized protein LOC107079889 isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 17 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
fibrinogen C domain containing 1, transcript variant X1
fibrinogen C domain containing 1, transcript variant X2
fibrinogen C domain containing 1, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
fibrinogen C domain-containing protein 1 isoform X1
fibrinogen C domain-containing protein 1 isoform X2
TNF receptor-associated factor 1-like, transcript variant X2
TNF receptor-associated factor 1-like, transcript variant X1
TNF receptor-associated factor 1-like isoform X1
TNF receptor-associated factor 1-like isoform X2
TNF receptor associated factor 1, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
TNF receptor associated factor 1, transcript variant X2
TNF receptor associated factor 1, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
TNF receptor associated factor 1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 20 samples with support for all annotated introns
PHD finger protein 19, transcript variant X1
PHD finger protein 19, transcript variant X3
PHD finger protein 19, transcript variant X2